ABRILADA 2 Contraindications

adalimumab

(

Abrilada is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container. For a complete listing, see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING.

  • Patients with severe infections such as sepsis, tuberculosis and opportunistic infections. See (3 SERIOUS WARNINGS AND PRECAUTIONS BOX, Serious Warnings and Precautions, Infections).
  • Patients with moderate to severe heart failure (NYHA class III/IV). See (7 WARNINGS ANDPRECAUTIONS, Cardiovascular, Patients with Congestive Heart Failure).
)

Find ABRILADA medical information:

Find ABRILADA medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

ABRILADA Quick Finder

Product Monograph
Download Product Monograph

Health Professional Information

2 Contraindications

Abrilada is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container. For a complete listing, see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING.

  • Patients with severe infections such as sepsis, tuberculosis and opportunistic infections. See (3 SERIOUS WARNINGS AND PRECAUTIONS BOX, Serious Warnings and Precautions, Infections).
  • Patients with moderate to severe heart failure (NYHA class III/IV). See (7 WARNINGS ANDPRECAUTIONS, Cardiovascular, Patients with Congestive Heart Failure).

Resources

Didn’t find what you were looking for? 

Contact us

Call 1-800-463-6001*

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: 1 866 723-7111.

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

Canada Vigilance Program 

You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect.